AbbVie

AbbVie is a pharmaceutical company that was founded in 2013 as a spin-off from Abbott Laboratories. The company focuses on the development of drugs for a range of therapeutic areas, including immunology, oncology, neuroscience, and virology. Some of their notable drugs include Humira (adalimumab) for rheumatoid arthritis and other autoimmune diseases, as well as Imbruvica (ibrutinib) for certain types of leukemia. They are known for their innovative research and development efforts in these areas.